|
US2016188792A1
|
|
Methods and Compositions for the Detection, Classification, and Diagnosis of Schizophrenia
|
|
US2014135945A1
|
|
Polymer nanofiber scaffold for a heparin/fibrin based growth factor delivery system
|
|
CN104640857A
|
|
Beta amino acid derivatives as integrin antagonists
|
|
US2013267428A1
|
|
High throughput digital karyotyping for biome characterization
|
|
WO2013036587A1
|
|
Foreign body location and retrieval device
|
|
WO2013020022A2
|
|
Methods and compositions for decomposition of biomass
|
|
WO2012177653A2
|
|
Targeting the neuromuscular junction for treatment
|
|
EP2568895A1
|
|
Distractor
|
|
US2011251515A1
|
|
Implantable pressure indicator with external interrogation
|
|
US2010145990A1
|
|
Selection and performance of hosted and distributed imaging analysis services
|
|
CN102159219A
|
|
Method of enhancing tgf-beta signalling
|
|
WO2010019494A1
|
|
Systems and methods for on-site and real-time electrocardiographic imaging (ecgi)
|
|
US2010015091A1
|
|
Modified stat1 transgene that confers interferon hyperresponsiveness, methods and uses therefor
|
|
US2009191645A1
|
|
Compounds and methods for modulating integrin activity
|
|
WO2009089341A1
|
|
Method for quantitatively mapping myocardial contractile function with magnetic resonance based multiparametric strain analysis
|
|
US2009171210A1
|
|
Sonoelectric tomography using a frequency-swept ultrasonic wave
|
|
WO2009076581A1
|
|
Fluctuations in amyloid beta as a biomarker for alzheimer's disease
|
|
EP2231263A2
|
|
Device for low-energy termination of atrial tachyarrhythmias
|
|
US2009184435A1
|
|
Controlling the synthesis and geometry of lipid tubule networks
|
|
WO2009062152A1
|
|
Methods for measuring the metabolism of cns derived biomolecules in vivo
|
